Patterson Companies (PDCO) Expected to Announce Earnings on Wednesday

Patterson Companies (NASDAQ:PDCOGet Free Report) is projected to post its quarterly earnings results before the market opens on Wednesday, February 26th. Analysts expect Patterson Companies to post earnings of $0.62 per share and revenue of $1.63 billion for the quarter. Patterson Companies has set its FY25 guidance at $2.25-$2.35 EPS and its FY 2025 guidance at 2.250-2.350 EPS.

Patterson Companies (NASDAQ:PDCOGet Free Report) last posted its quarterly earnings data on Thursday, December 5th. The company reported $0.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by ($0.02). Patterson Companies had a return on equity of 19.77% and a net margin of 2.37%. The company had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same quarter in the previous year, the firm posted $0.50 EPS. The business’s revenue for the quarter was up 1.0% compared to the same quarter last year. On average, analysts expect Patterson Companies to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Patterson Companies Stock Performance

NASDAQ:PDCO opened at $31.05 on Wednesday. The firm’s 50-day moving average is $30.78 and its 200-day moving average is $25.03. Patterson Companies has a 52-week low of $19.45 and a 52-week high of $31.79. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.76 and a current ratio of 1.37. The company has a market cap of $2.74 billion, a price-to-earnings ratio of 18.16, a PEG ratio of 2.70 and a beta of 0.90.

Insiders Place Their Bets

In other news, CEO Donald Zurbay sold 1,962 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $23.08, for a total transaction of $45,282.96. Following the transaction, the chief executive officer now directly owns 222,736 shares in the company, valued at approximately $5,140,746.88. This represents a 0.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on PDCO. Leerink Partners reissued a “market perform” rating and issued a $31.35 target price (up previously from $29.00) on shares of Patterson Companies in a research note on Wednesday, December 11th. StockNews.com began coverage on shares of Patterson Companies in a research note on Saturday. They issued a “hold” rating on the stock. Stifel Nicolaus lowered their target price on shares of Patterson Companies from $25.00 to $24.00 and set a “hold” rating on the stock in a research note on Thursday, December 5th. Leerink Partnrs cut shares of Patterson Companies from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Finally, Robert W. Baird upped their target price on shares of Patterson Companies from $25.00 to $31.00 and gave the company a “neutral” rating in a research note on Thursday, December 12th. Eleven equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, Patterson Companies has a consensus rating of “Hold” and a consensus price target of $26.57.

Read Our Latest Analysis on Patterson Companies

Patterson Companies Company Profile

(Get Free Report)

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.

Further Reading

Earnings History for Patterson Companies (NASDAQ:PDCO)

Receive News & Ratings for Patterson Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patterson Companies and related companies with MarketBeat.com's FREE daily email newsletter.